GO:0006882 intracellular zinc ion homeostasis: Cellular Zinc Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006882 (intracellular zinc ion homeostasis) describes the biological process that maintains a steady-state level of zinc ions within a cell, encompassing buffering, muffling, storage, and transport.
• Cytosolic zinc buffering and muffling are distinct mechanisms that protect cells from zinc toxicity while preserving zinc-dependent signaling.
• Metallothioneins and zinc transporters (SLC30A/ZnT and SLC39A/ZIP families) are central to zinc homeostasis and are implicated in immune function, diabetes, and cancer.
• The secretory pathway in yeast requires dedicated zinc homeostasis machinery, highlighting evolutionarily conserved principles.
• Dysregulated intracellular zinc homeostasis contributes to cancer progression, diabetes, and immune dysfunction, making it a therapeutic target.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of zinc homeostasis genes in human cells.
Description
Intracellular zinc ion homeostasis (GO:0006882) is the biological process that maintains a steady-state level of zinc ions within a cell. Zinc is an essential trace element that serves as a catalytic cofactor for hundreds of enzymes and as a structural component of transcription factors, but free zinc can also be cytotoxic; therefore, cells have evolved sophisticated buffering and muffling systems to keep cytosolic zinc within a narrow physiological range. This process is fundamental to cell biology because zinc signals participate in immune function, insulin storage and secretion, and protection against oxidative stress. The importance of intracellular zinc ion homeostasis extends to human disease. Disruption of zinc balance has been linked to cancer progression, where the USP2-E2F4 axis regulates autophagic machinery essential for zinc homeostasis. In diabetes, zinc transport and storage defects impair pancreatic beta-cell function. Immune cells rely on zinc as a gatekeeper of function, and zinc deficiency compromises both innate and adaptive immunity. Moreover, metal transporters such as ZIP13 sit at the crossroads of intracellular zinc and iron homeostasis, illustrating crosstalk between metal ions. For researchers, GO:0006882 provides a framework to study how cells sense, buffer, store, and mobilize zinc. The process involves cytosolic buffering by metallothioneins and other ligands, muffling through transport into organelles or out of the cell, and regulated expression of zinc transporters. Understanding these mechanisms at the molecular level is essential for developing therapies that target zinc homeostasis in cancer, metabolic disease, and immune disorders.
intracellular zinc ion homeostasis At A Glance
| GO ID | GO:0006882 |
|---|---|
| GO term | intracellular zinc ion homeostasis |
| Ontology | biological_process |
| Synonym | cellular zinc ion homeostasis; zinc homeostasis |
| Major function | Maintenance of a steady-state level of zinc ions within a cell |
| Key mechanisms | Cytosolic buffering, muffling, vesicular storage, and transmembrane transport |
| Key molecules | Metallothioneins, SLC30A/ZnT exporters, SLC39A/ZIP importers |
| Disease relevance | Cancer, diabetes, immune dysfunction, metal overload disorders |
What Is GO:0006882?
Intracellular zinc ion homeostasis (GO:0006882) is defined as a homeostatic process involved in the maintenance of a steady state level of zinc ions within a cell. In other words, it encompasses all cellular activities that keep the concentration of free zinc ions within a physiological range, including buffering by cytosolic molecules, muffling via transport and storage, and regulated expression of zinc-handling proteins.
Why Is intracellular zinc ion homeostasis Important in Cell Biology?
Intracellular zinc ion homeostasis is critical because zinc is both essential and potentially toxic. Cells must maintain free zinc at picomolar to low nanomolar levels while allowing rapid zinc signals for processes such as immune activation, insulin secretion, and apoptosis regulation. Disruption of this balance contributes to cancer progression, metabolic disease, and immune deficiency, making GO:0006882 a central node for therapeutic intervention.
• Zinc is a catalytic and structural cofactor for thousands of proteins, requiring tight homeostatic control.
• Cytosolic zinc buffering and muffling protect cells from zinc-induced toxicity.
• Metallothioneins store and release zinc, modulating its availability for signaling.
• Zinc transporters of the SLC30A (ZnT) and SLC39A (ZIP) families mediate zinc efflux, influx, and organellar sequestration.
• Zinc homeostasis is a gatekeeper of immune function, affecting both innate and adaptive immunity.
• Dysregulated zinc homeostasis is implicated in diabetes and pancreatic beta-cell dysfunction.
• The USP2-E2F4 axis links zinc homeostasis to autophagy in cancer progression.
• ZIP13 connects intracellular zinc and iron homeostasis, revealing metal crosstalk.
• The secretory pathway requires dedicated zinc homeostasis mechanisms in yeast.
• Nanoenabled regulation of intracellular metal ion homeostasis is an emerging therapeutic strategy for tumors.
What Happens During intracellular zinc ion homeostasis?
Zinc buffering by cytosolic ligands
In simple terms: Cells use small molecules and proteins to temporarily hold zinc, preventing it from reaching toxic levels.
Cytosolic zinc buffering refers to the reversible binding of zinc ions by low-molecular-weight ligands such as glutathione and by proteins including metallothioneins. This buffering capacity determines the size of the labile zinc pool and protects against sudden zinc influx. Metallothioneins are cysteine-rich proteins that sequester zinc and release it upon demand, thereby contributing to zinc homeostasis.
Zinc muffling via transport and storage
In simple terms: When zinc levels rise, cells move zinc into storage compartments or pump it out to avoid damage.
Zinc muffling is the process by which cells reduce the concentration of free zinc by transporting it into organelles (e.g., lysosomes, endoplasmic reticulum, mitochondria) or out of the cell. This involves zinc transporters such as ZnT (SLC30A) family members, which mediate efflux from the cytosol, and ZIP (SLC39A) family members, which mediate influx. The secretory pathway in yeast requires specific zinc homeostasis machinery to ensure proper protein folding and function.
Regulated expression of zinc transporters and metallothioneins
In simple terms: Cells adjust the number of zinc-handling proteins to match zinc availability and demand.
The expression of zinc transporters and metallothioneins is transcriptionally regulated by zinc-responsive transcription factors such as MTF-1 in metazoans. This feedback loop ensures that zinc uptake, storage, and export are balanced. In cancer, the USP2-E2F4 axis regulates autophagic machinery essential for zinc homeostasis, linking zinc regulation to cellular stress responses.
Zinc signaling and release from intracellular stores
In simple terms: Zinc can be released from storage sites to act as a signal inside cells.
Beyond static buffering, zinc ions are mobilized from intracellular stores (e.g., metallothioneins, lysosomes, and the endoplasmic reticulum) to participate in signaling events. This release can modulate enzyme activity, gene expression, and immune responses. In pancreatic beta cells, zinc is stored in insulin granules and co-released with insulin, influencing glucose homeostasis.
Crosstalk with other metal ions
In simple terms: Zinc balance is connected to the balance of other metals like iron.
Intracellular zinc homeostasis does not operate in isolation. The metal transporter ZIP13 (SLC39A13) is involved in both zinc and iron homeostasis, and its dysfunction can affect connective tissue and bone development. Such crosstalk means that perturbations in zinc handling can have secondary effects on iron metabolism and vice versa.
Key Genes Involved in GO:0006882 intracellular zinc ion homeostasis
The following genes and proteins are central to intracellular zinc ion homeostasis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MT1A | Metallothionein isoform that binds and sequesters zinc | Zinc buffering and detoxification; biomarker of zinc status |
| MT2A | Metallothionein involved in zinc storage and release | Zinc homeostasis and protection against oxidative stress |
| SLC30A1 (ZnT1) | Zinc exporter at the plasma membrane | Cellular zinc efflux; resistance to zinc toxicity |
| SLC30A2 (ZnT2) | Vesicular zinc transporter in secretory tissues | Zinc secretion into milk and pancreatic juice |
| SLC30A3 (ZnT3) | Transports zinc into synaptic vesicles | Neuronal zinc signaling and cognition |
| SLC30A8 (ZnT8) | Zinc transporter in pancreatic beta cells | Insulin granule zinc storage; diabetes risk |
| SLC39A1 (ZIP1) | Zinc importer at the plasma membrane | Cellular zinc uptake; cancer proliferation |
| SLC39A4 (ZIP4) | Intestinal zinc absorption | Acrodermatitis enteropathica; zinc deficiency |
| SLC39A6 (ZIP6) | Zinc importer involved in epithelial-mesenchymal transition | Cancer metastasis and zinc signaling |
| SLC39A13 (ZIP13) | Zinc and iron transporter in connective tissue | Spondylocheirodysplastic Ehlers-Danlos syndrome |
| USP2 | Deubiquitinase regulating E2F4 stability | Autophagic machinery and zinc homeostasis in cancer |
| E2F4 | Transcription factor controlling autophagy genes | Zinc homeostasis and cancer progression |
| MTF1 | Zinc-responsive transcription factor | Induction of metallothioneins and zinc transporters |
| COMMD1 | Copper metabolism protein with links to zinc | Metal homeostasis crosstalk |
| ATP7A | Copper transporter with zinc interactions | Menkes disease; metal crosstalk |
| ATP7B | Copper transporter with zinc interactions | Wilson disease; metal crosstalk |
How Is intracellular zinc ion homeostasis Regulated?
Intracellular zinc ion homeostasis is regulated at multiple levels. Transcriptionally, the zinc-sensing transcription factor MTF1 activates the expression of metallothioneins and zinc transporters in response to zinc excess. Post-translationally, zinc transporters can be regulated by trafficking and degradation. In cancer, the USP2-E2F4 axis controls autophagic machinery that is essential for zinc homeostasis, linking zinc regulation to autophagy and tumor progression. Additionally, zinc homeostasis intersects with immune signaling, where zinc availability modulates immune cell function. The secretory pathway in yeast also requires specific regulatory mechanisms to maintain zinc homeostasis.
intracellular zinc ion homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC30A8 (ZnT8) | Type 2 diabetes | Knockout and point-mutation in pancreatic beta cells |
| USP2 | Cancer progression via autophagy | Knockout and overexpression in cancer cell lines |
| SLC39A13 (ZIP13) | Spondylocheirodysplastic Ehlers-Danlos syndrome | Knock-in of patient mutations in fibroblasts |
| MT1A/MT2A | Zinc dysregulation in cancer and inflammation | Knockout and overexpression in immune cells |
| SLC39A4 (ZIP4) | Acrodermatitis enteropathica | Knockout in intestinal epithelial cells |
Cancer
Dysregulated intracellular zinc homeostasis is a hallmark of many cancers. The USP2-E2F4 axis regulates autophagic machinery essential for zinc homeostasis, and targeting this axis inhibits cancer progression. Zinc transporters such as ZIP6 and ZIP10 are associated with metastasis, and metallothionein expression is often altered in tumors. Nanoenabled regulation of intracellular metal ion homeostasis has emerged as a therapeutic strategy for tumor therapy.
Diabetes
Zinc plays a critical role in pancreatic beta-cell function, where it is stored in insulin granules via ZnT8 (SLC30A8). Polymorphisms in SLC30A8 are associated with type 2 diabetes risk, and zinc supplementation has been explored for glycemic control. Zinc homeostasis is therefore a key area in diabetes research.
Immune dysfunction
Zinc is a gatekeeper of immune function. Zinc deficiency impairs both innate and adaptive immunity, leading to increased susceptibility to infections. Intracellular zinc homeostasis is required for proper immune cell activation, proliferation, and cytokine production.
Metal overload and connective tissue disorders
Mutations in SLC39A13 (ZIP13) cause a rare connective tissue disorder characterized by skeletal abnormalities, highlighting the importance of zinc homeostasis in bone and connective tissue. ZIP13 also links zinc and iron homeostasis, and its dysfunction can lead to metal imbalance.
From intracellular zinc ion homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC30A8 affect insulin secretion? | SLC30A8 knockout in pancreatic beta cells |
| Does a diabetes-associated SLC30A8 variant alter zinc transport? | Point mutation knock-in of the variant |
| Can zinc transporter tagging reveal subcellular localization? | Tagged knock-in of SLC30A8 with fluorescent protein |
| Does overexpression of MT2A protect against zinc toxicity? | MT2A overexpression in HEK293 or HeLa cells |
| Which genes regulate zinc homeostasis in cancer? | CRISPR library screening in cancer cell lines |
| Does ZIP13 mutation affect iron homeostasis? | ZIP13 knockout and knock-in in fibroblasts |
How to Study the intracellular zinc ion homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent zinc sensors (ZapCY, eCALWY) | Free zinc concentration in live cells | Monitoring cytosolic and organellar zinc dynamics |
| RNA-seq | Transcript levels of zinc transporters and metallothioneins | Identifying zinc-responsive gene networks |
| Proteomics | Protein abundance and zinc-binding proteins | Metalloproteomic profiling |
| CRISPR knockout screening | Gene essentiality under zinc stress | Discovering regulators of zinc homeostasis |
| ICP-MS | Total zinc content in cells or tissues | Quantifying zinc accumulation |
| Western blot | Protein expression of ZIP/ZnT transporters | Validating knockout or overexpression |
| Immunofluorescence | Subcellular localization of zinc transporters | Studying trafficking and organelle distribution |
Fluorescent zinc sensors
Genetically encoded fluorescent sensors such as ZapCY or eCALWY can measure free zinc concentrations in live cells with subcellular resolution. These tools allow researchers to monitor changes in cytosolic, mitochondrial, and endoplasmic reticulum zinc pools in real time.
Transcriptomics and RNA-seq
RNA sequencing can quantify expression changes in metallothioneins and zinc transporters following zinc exposure or genetic perturbation. This approach helps identify transcriptional networks regulated by MTF1 and other zinc-responsive factors.
Proteomics and metalloproteomics
Mass spectrometry-based proteomics can identify zinc-binding proteins and quantify metallothionein levels. Metalloproteomic approaches reveal changes in zinc distribution among proteins under different conditions.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that modify cellular fitness under zinc stress or that regulate zinc homeostasis. Such screens have uncovered components of the USP2-E2F4 axis and autophagy-related genes.
How CRISPR Can Be Used to Study GO:0006882 intracellular zinc ion homeostasis
Knockout
CRISPR knockout of genes such as SLC30A8, MT1A, or USP2 allows researchers to assess their causal role in intracellular zinc homeostasis. For example, SLC30A8 knockout in beta cells impairs zinc storage in insulin granules and alters glucose-stimulated insulin secretion. Knockout of USP2 affects autophagic machinery and zinc homeostasis in cancer cells.
Point Mutation
Point mutation knock-in can model disease-associated variants, such as the SLC30A8 R138X or other polymorphisms linked to type 2 diabetes. These models help determine whether a specific amino acid change alters zinc transport activity or protein stability.
Knock-in
Knock-in of tagged versions of zinc transporters (e.g., GFP-SLC30A8) enables live-cell imaging of subcellular localization and trafficking. Knock-in of patient mutations in SLC39A13 (ZIP13) can recapitulate connective tissue defects in cell models.
Overexpression
Overexpression of metallothioneins (MT1A, MT2A) or zinc transporters can test whether increased buffering or transport capacity protects against zinc toxicity or alters signaling. Overexpression of ZIP6 has been used to study epithelial-mesenchymal transition and metastasis.
How EDITGENE Supports intracellular zinc ion homeostasis Research
Researchers studying intracellular zinc ion homeostasis-related genes often need to determine whether a candidate gene is causally involved in zinc regulation, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for intracellular zinc ion homeostasis research.
Frequently Asked Questions About intracellular zinc ion homeostasis
What is intracellular zinc ion homeostasis?
Intracellular zinc ion homeostasis (GO:0006882) is the biological process that maintains a steady-state level of zinc ions within a cell, involving buffering, muffling, storage, and transport.
What genes are involved in intracellular zinc ion homeostasis?
Key genes include metallothioneins (MT1A, MT2A), zinc transporters (SLC30A/ZnT and SLC39A/ZIP families), and regulatory factors such as MTF1 and USP2.
Why is zinc homeostasis important for immune function?
Zinc acts as a gatekeeper of immune function; zinc deficiency impairs both innate and adaptive immunity, affecting immune cell activation and cytokine production.
How is zinc homeostasis linked to diabetes?
Zinc is stored in insulin granules via ZnT8 (SLC30A8), and polymorphisms in SLC30A8 are associated with type 2 diabetes risk; zinc homeostasis is critical for beta-cell function.
What is the role of metallothioneins in zinc homeostasis?
Metallothioneins are cysteine-rich proteins that bind and sequester zinc, contributing to zinc buffering, storage, and detoxification.
How does the USP2-E2F4 axis regulate zinc homeostasis?
The USP2-E2F4 axis controls autophagic machinery essential for zinc homeostasis, and targeting this axis inhibits cancer progression.
What is zinc buffering versus zinc muffling?
Zinc buffering is the reversible binding of zinc by cytosolic ligands, while muffling is the transport of zinc into organelles or out of the cell to reduce free zinc levels.
Can CRISPR be used to study zinc homeostasis?
Yes, CRISPR knockout, knock-in, and overexpression models allow causal dissection of genes involved in zinc homeostasis, such as SLC30A8 and MT1A.
What diseases are associated with disrupted zinc homeostasis?
Disrupted zinc homeostasis is linked to cancer, diabetes, immune dysfunction, and connective tissue disorders such as those caused by ZIP13 mutations.
How can I measure intracellular zinc levels?
Fluorescent zinc sensors (e.g., ZapCY, eCALWY) and ICP-MS are commonly used to measure free and total zinc concentrations in cells.
Conclusion
Intracellular zinc ion homeostasis (GO:0006882) is a fundamental biological process that safeguards cells from zinc toxicity while enabling zinc-dependent signaling. Its dysregulation contributes to cancer, diabetes, immune disorders, and metal overload diseases. Understanding the molecular players, including metallothioneins, zinc transporters, and regulatory factors such as USP2-E2F4, offers opportunities for therapeutic intervention. CRISPR-based models are indispensable for dissecting these mechanisms and translating findings into clinical applications.
References
- 1. Xu L et al.. 2024. Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy.. Adv Sci (Weinh) 11(7):e2306203 PMID: 38063781
- 2. Wessels I et al.. 2017. Zinc as a Gatekeeper of Immune Function.. Nutrients 9(12) PMID: 29186856
- 3. Xiao W et al.. 2022. Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.. Autophagy 18(11):2615-2635 PMID: 35253629
- 4. Colvin RA et al.. 2010. Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis.. Metallomics 2(5):306-17 PMID: 21069178
- 5. Bird AJ et al.. 2020. Zinc homeostasis in the secretory pathway in yeast.. Curr Opin Chem Biol 55:145-150 PMID: 32114317
- 6. Fukunaka A et al.. 2026. Metal transporter ZIP13 at the crossroads of intracellular zinc and iron homeostasis.. Biosci Biotechnol Biochem 90(4):483-490 PMID: 41277712
- 7. Chabosseau P et al.. 2016. Zinc and diabetes.. Arch Biochem Biophys 611:79-85 PMID: 27262257
- 8. Baltaci AK et al.. 2018. Zinc Metabolism and Metallothioneins.. Biol Trace Elem Res 183(1):22-31 PMID: 28812260
